Traditionally, surgical resection has been the treatment of choice in many patients with hepatocellular adenoma because of the risk of rupture, hemorrhage and malignant transformation. However, some patients are not amenable for surgery due to the extensive involvement of the liver, as in patients with liver adenomatosis. We report 2 cases with liver adenomatosis in which we combined surgery with open and percutaneous radiofrequency ablation for lesions located in both lobes of the liver. Minimal invasive treatment including radiofrequency ablation may offer new perspectives in the treatment of patients with liver adenomatosis.

Keywords:
Hepatocellular adenoma, Liver adenomatosis, Minimal invasive treatment, Radiofrequency ablation
1.
de Rave S, Hussain SM: A liver tumour as an incidental finding: differential diagnosis and treatment. Scand J Gastroenterol Suppl 2002:81–86.
2.
Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Tilanus HW, IJzermans JN: Treatment of ruptured hepatocellular adenoma. Br J Surg 2001;88:207–209.
3.
Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR, Martin RC, D’Angelica M, Staley CA, Choti MA, Jarnagin WR, Schulick RD, Kooby DA: Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009;16:640–648.
4.
Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M: Malignant transformation of hepatic adenomas. Mod Pathol 2008;21:491–497.
5.
Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, Balabaud C, Zucman-Rossi J: Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740–748.
6.
Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P: Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006;43:515–524.
7.
Bioulac-Sage P, Laumonier H, Rullier A, Cubel G, Laurent C, Zucman-Rossi J, Balabaud C: Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 2009;29:459–465.
8.
Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, Benhamou JP: Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985;89:1132–1138.
9.
Cobey FC, Salem RR: A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004;187:181–191.
10.
Cho SW, Marsh JW, Steel J, Holloway SE, Heckman JT, Ochoa ER, Geller DA, Gamblin TC: Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 2008;15:2795–2803.
11.
Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J: A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009;137:1698–1705.
12.
van der Windt DJ, Kok NF, Hussain SM, Zondervan PE, Alwayn IP, de Man RA, JN IJ: Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 2006;93:1495–1502.
13.
Fujita S, Kushihata F, Herrmann GE, Mergo PJ, Liu C, Nelson D, Fujikawa T, Hemming AW: Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. J Gastroenterol Hepatol 2006;21:1351–1354.
14.
Atwell TD, Brandhagen DJ, Charboneau JW, Nagorney DM, Callstrom MR, Farrell MA: Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. AJR Am J Roentgenol 2005;184:828–831.
15.
Rhim H, Lim HK, Kim YS, Choi D: Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J Gastroenterol Hepatol 2008;23:e422–427.
16.
Rocourt DV, Shiels WE, Hammond S, Besner GE: Contemporary management of benign hepatic adenoma using percutaneous radiofrequency ablation. J Pediatr Surg 2006;41:1149–1152.
17.
van der Sluis FJ, Bosch JL, Terkivatan T, de Man RA, Ijzermans JN, Hunink MG: Hepatocellular adenoma: cost-effectiveness of different treatment strategies. Radiology 2009;252:737–746.
18.
Stoot JH, Coelen RJ, De Jong MC, Dejong CH: Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010;12:509–522.
19.
Kobayashi S, Sakaguchi H, Takatsuka M, Suekane T, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N: Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization. Hepatol Int 2009;3:416–420.
20.
Laurent C, Trillaud H, Lepreux S, Balabaud C, Bioulac-Sage P: Association of adenoma and focal nodular hyperplasia: experience of a single French academic center. Comp Hepatol 2003;2:6.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.